Literature DB >> 16566262

Evaluation of antigen-capture ELISA and immunohistochemical methods for avian surveillance of West Nile virus.

Jennifer A Godhardt1, Kerry Beheler, Michael J O'Connor, T J Whyte, Erik S Reisdorf, Susan J Ubl, Philip N Bochsler, Kathy L Toohey-Kurth.   

Abstract

Accurate detection of West Nile virus (WNV) in corvids is essential for monitoring the spread of virus during the mosquito season. Viremia in corvids is very high, with titers approaching 10(8) viral particles/ml. In the presence of such marked viremia, the sensitivity of real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis is unnecessary, and more cost-effective methods should be assessed. To this end, antigen-capture ELISA (ACE) and immunohistochemical (IHC) assays were evaluated. Skin, cloacal swab specimens, and feathers from corvids were tested by use of ACE, and results were compared with results obtained from use of real-time RT-PCR analysis. Of the 3 sample types, skin gave the best sensitivity (98%) and specificity (100%). Skin, brain, kidney, and spleen from corvids were analyzed by IHC, and results were compared with real-time RT-PCR results. Kidney and spleen were more often positive by use of IHC than were brain and skin tissue; however, IHC did not perform as well as ACE in the identification of virus-positive birds. Results of this study support the use of a skin sample in an ACE format as an effective surveillance method for corvids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566262     DOI: 10.1177/104063870601800112

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  1 in total

1.  Sensitivity and specificity of monoclonal and polyclonal immunohistochemical staining for West Nile virus in various organs from American crows (Corvus brachyrhynchos).

Authors:  Rebecca C Smedley; Jon S Patterson; RoseAnn Miller; Jeffrey P Massey; Annabel G Wise; Roger K Maes; Ping Wu; John B Kaneene; Matti Kiupel
Journal:  BMC Infect Dis       Date:  2007-05-30       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.